Clinical Trial Update: Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study evaluating the efficacy of mirabegron for treating non-monosymptomatic nocturnal enuresis in children, with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-monosymptomatic Nocturnal Enuresis

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: Menoufia University | Conditions: Treatment of Non-monosymptomatic Nocturnal Enuresis | Phase 3 | Status: ACTIVE_NOT_RECRUITING